Introduction
Most eukaryotic cells use the mitochondrial electron transport chain and oxidative phosphorylation to generate ATP under aerobic conditions. The production of ATP is catalyzed by the terminal enzyme of the oxidative phosphorylation pathway, the F-ATPase (also called F 1 F o -ATPase or ATP synthase). Together with respiratory enzyme complexes I, II, III, and IV, the F-ATPase is located in the inner mitochondrial membrane where it uses the electrochemical potential difference for protons across the membrane generated by complexes I, III and IV. The proton flux from the intermembrane space, through the membrane domain of the F-ATPase, into the mitochondrial matrix, drives the turning of the enzyme's rotor. The rotor is composed of a ring of c-subunits in the membrane sector of the enzyme, attached to an elongated central stalk, which lies along the six-fold axis of pseudo-symmetry in the membrane-extrinsic F 1 -catalytic domain. This rotation drives the sequential binding of substrates ADP and phosphate and the formation of ATP in each of the three catalytic sites, which are found at interfaces between a-and b-subunits in the F 1 -domain (for reviews see ref. [1, 2] ). The enzyme can also act in reverse to hydrolyze ATP, changing the direction of rotation of the rotor, and pumping protons from the mitochondrial matrix into the intermembrane space. Under certain conditions, for example, during anoxia, this reverse mechanism counteracts the depolarization of the inner mitochondrial membrane. However, in order to minimize the risk of deleterious depletion of ATP, this proton translocation at the expense of ATP is tightly regulated [3] by a mechanism involving an inhibitor protein, known as IF 1 . This protein is found throughout eukaryotes, and has been studied mainly in bovine, human, and yeast mitochondria. The bovine protein is a potent unidirectional inhibitor of the ATP hydrolytic activity of the F-ATPase, without effect on the synthesis of ATP [4, 5] . The active form of bovine IF 1 is a dimer where the monomers are held together by an a-helical coiled-coil in the C-terminal regions of the two protein monomers. In the free dimeric inhibitor, near neutral pH, the N-terminal inhibitory region is intrinsically unfolded, whereas under slightly alkaline conditions (ca. pH 8.0), IF 1 becomes inactive by formation of dimers of dimers and higher aggregates that mask the inhibitory region [6, 7] . The formation of the fully inhibited state of the ATPase requires the hydrolysis of two ATP molecules. In the structure of the bovine F 1 -ATPase inhibited by a monomeric form of IF 1 (known as I1-60 and consisting of the residues 1-60), the largely a-helical N-terminal region of the inhibitor is bound in a deep groove at the most closed of the three catalytic interfaces of bovine F 1 -ATPase. Here, it makes contacts with five of the nine subunits of the enzyme [8] . In the presence of a large molar excess of either unmodified I1-60 or a mutated monomeric form carrying the mutation K39A, the inhibited F 1 -ATPase complex has two or three molecules of IF 1 bound at catalytic interfaces. These complexes represent intermediate stages in the binding of IF 1 to F 1 -ATPase in the pathway from the unbound and unfolded inhibitory region to the progressively folded and final fully folded inhibited state of F 1 -ATPase [9] . The inhibitor protein from Saccharomyces cerevisiae binds to yeast F 1 -ATPase in a closely similar manner to the binding of bovine IF 1 to bovine F 1 -ATPase [10] . Moreover, bovine IF 1 is an effective inhibitor of yeast F 1 -ATPase and vice versa [11, 12] . However, yeast IF 1 is monomeric, not dimeric, as it lacks the C-terminal dimerization domain, and so its activity is not regulated by the formation of higher oligomers [12, 13] . In human mitochondria, IF 1 has been reported to protect cardiac tissue against the loss of ATP during ischemia [14, 15] , has been linked to anti-apoptotic activity and oncogenesis in various cell lines and tissues [16, 17] , and has been proposed to play an important role in the in vivo process of assembly of ATP synthase, by acting to prevent partially assembled complexes with the capability to hydrolyze ATP from doing so [18] .
The parasitic flagellate, Trypanosoma brucei is the causative agent of sleeping sickness. It has a complex life cycle, including two main proliferative stages, the procyclic form (PF) in the tsetse fly (Glossina sp.) and the bloodstream form (BF) in the final mammalian host [19] . As these two stages occur in entirely different environments, they differ fundamentally in cell morphology and physiology, including their mechanisms of energy conversion [20] . In the PF, ATP is produced mostly by oxidative phosphorylation where the F-ATPase generates ATP [21] . In contrast, the BF is supplied by virtually unlimited glucose from the blood of the host, and ATP is provided by glycolysis. The BF mitochondria are devoid of respiratory complexes III and IV, and complex I is non-essential and dispensable. Instead, reducing equivalents are channeled via the alternative NADH dehydrogenase, and the electrons are transferred to oxygen by the nonproton pumping alternative oxidase (for reviews see ref. [22, 23] ). The essential mitochondrial membrane potential is maintained by the proton pumping activity of the F-ATPase driven by the hydrolysis of ATP [24, 25] . The genome of T. brucei encodes an ATPase inhibitor protein known as TbIF 1 . However, as expected, it is expressed only in PF cells. Ectopic expression of TbIF 1 in the BF stage causes the collapse of the mitochondrial membrane potential and a rapid inhibition of growth [26] .
As described below, we have characterized TbIF 1 and its binding in vitro to its cognate F 1 -ATPase. We have defined the regions of TbIF 1 that are essential for the inhibitory activity. We have compared the sensitivity of its activity to pH, and its ability to form homo-oligomers with the bovine ortholog, and demonstrated that TbIF 1 is incapable of inhibiting the bovine enzyme. Therefore, since the hydrolytic activity of the F-ATPase is absolutely required in the BF of T. brucei, compounds mimicking the action of TbIF 1 could be developed to selectively inhibit the parasite F-ATPase without affecting the human enzyme as new therapies for the treatment of sleeping sickness and related African trypanosomiases.
Results and Discussion

Characterization of TbIF 1 and variants
In order to characterize TbIF 1 and to study how its features are involved in the inhibition of F 1 -ATPase in T. brucei, several variants of TbIF 1 were expressed in Escherichia coli without the N-terminal mitochondrial targeting sequence (Fig. 1A) and with a C-terminal 6xHis tag used in their purification by affinity chromatography. The proteins include the intact mature TbIF 1 from residues 1-93 and named TbIF 1 -WT, a C-terminally truncated version, TbIF 1 , N-terminally truncated versions TbIF 1 -D1-5, -D1-8, -D1-10, -D1-12 and -D1-15, and full-length forms with point mutations, TbIF 1 (E24A), TbIF 1 (E27A), TbIF 1 (P32A) and TbIF 1 (Y24W). The purity of the isolated proteins was demonstrated by analysis by SDS/PAGE (Fig. 1B) , and their sequences were verified by measurement of their intact molecular masses (Table S1 ). The choice of these mutated forms of TbIF 1 was based upon knowledge of the mode of action of the bovine and yeast inhibitor proteins, and on sequence relationships between these proteins and other orthologs with TbIF 1 (Fig. 1A) . This sequence alignment demonstrates that the inhibitory region from residues 19-59 is well conserved, especially from residues F25 to L48, which forms the a-helical region that interacts with F 1 -ATPase in the bovine and yeast enzymes, except that residues R25, A28, F34, A43, and A44 [27] , identified as being critical for the binding of bovine IF 1 to its cognate F 1 -ATPase, are not conserved in TbIF 1 (Table S2 ).
The N-terminal inhibitory domain of the bovine IF 1 is intrinsically disordered and becomes progressively structured in the process of binding to F 1 -ATPase [9] . The CD spectrum of TbIF 1 -WT is typical of a protein with high a-helical content [28] , whereas the spectrum of TbIF 1 (1-64) is typical of a random structure (Fig. 1C) . Thus, it appears that the conserved N-terminal part of TbIF 1 is intrinsically unfolded, as in bovine IF 1 , and the a-helical component of the CD spectrum comes from the C-terminal region where residues 33-93 are predicted to form a single a-helix (Fig. 1A) with the potential to form an anti-parallel a-helical coiled-coil (residues 60-93), as in bovine IF 1 [29] .
In contrast to the conservation of the sequence of residues 25-88, residues 1-24 of TbIF 1 are largely 1 sequences from various species. TbIF 1 has not been characterized from a native source, and therefore the exact point where the mitochondrial import precursor is cleaved is not known experimentally. However, the cleavage site is predicted to occur following residue 22 of the precursor making serine 23 of the precursor to be residue 1 of the mature protein. The numbering of the mature protein is used in this figure. The secondary structure was predicted with Jpred [41] , and regions with the capacity to form a-helical coils were predicted with Paircoil2 [29] . In this study, truncated versions of TbIF 1 with residues 1-5, 1-8, 1-10, 1-12 and 1-15 deleted are described. In other forms of TbIF 1 , specific residues (red) were mutated to alanine and Tyr-36 was mutated to tryptophan. The alignment of the sequences of TbIF 1 with inhibitor proteins from other species was generated with MUSCLE [42] . The similarities of residues highlighted in black, dark gray, and light gray as calculated with the Blossum 62 scoring matrix and threshold set to 1 are 100%, < 100% and ≥ 80%, and < 80% and ≥ 60%, respectively. Lm, Leishmania major; Tb, Trypanosoma brucei; Sc, Saccharomyces cerevisiae; Ce, Caenorhabditis elegans; Bt, Bos taurus; Hs, Homo sapiens. unconserved. The region from residues 1-18 is predicted to be unstructured, and the regions from 19 to 27 and 33 to 93 to be a-helical. In the bovine enzyme, the N-terminal region from residues 1-13 is also unstructured and makes contact the a E -subunit. Residues 14-18 form a short a-helix which is in contact with the N-terminal a-helix of the c-subunit [8, 10] , thereby contributing to the strength of the interaction between the enzyme and the inhibitor [27] . The sequence alignment also revealed a stretch of residues starting at I49 of TbIF 1 , which appears to be specific for kinetoplastids (Fig. 1A) .
Oligomerization of TbIF 1
The ability of TbIF 1 to form homo-oligomers was examined by two independent approaches. It was demonstrated by covalent cross-linking with dimethyl suberimidate (DMS) that, similar to the bovine protein, TbIF 1 -WT forms dimers at pH values above neutrality, whereas TbIF 1 (1-64) did not ( Fig. 2A) . However, the higher oligomers observed with the bovine protein were not formed by TbIF 1 -WT. The oligomerization state was examined also by gel filtration chromatography (Table 1 and Fig. 2B ). With the control samples, monomeric bovine I1-60 and full length bovine IF 1 , the values obtained at pH 8.0 were approximately twice those expected for monomers and dimers, probably in consequence of the dimers consisting of a partly of an antiparallel a-helical coiled coil structure approximately 130
A long involving residues 19-81, with a disordered structure from residues 1-18 extending in opposite directions from each monomer [7] . The values obtained with TbIF 1 -WT and TbIF 1 were similarly greater than expected from their calculated molecular masses. By comparison with the bovine values, and assuming that TbIF 1 has a similar overall structure to bovine IF 1 , which the sequence similarities suggest, the observed values are consistent with TbIF 1 (1-64) being monomeric, and the formation of dimers by TbIF 1 both above and below neutral pH. In contrast to the bovine protein, TbIF 1 appears not to form oligomers greater than dimers under any of the conditions that were investigated. Therefore, it appears that in contrast to bovine IF 1 , where the transition from the active dimeric state to the inactive tetrameric and higher oligomeric states is governed by pH [6] , TbIF 1 does not form dimers of dimers and higher oligomers at pH 8.0, and there is no evidence for a pH regulated active-inactive switch with TbIF 1 .
Influence of pH and the C-terminal region of TbIF 1 on its inhibitory activity
The kinetics of the inhibition of F 1 -ATPase by TbIF 1 were characterized by measurement of the rate constants of the inhibitor's binding (k on ) and dissociation (k off ), and the dissociation constant of the inhibitorenzyme complex (K i ). The kinetic measurements were carried out with F 1 -ATPase isolated from the PF of T. brucei [30] . These kinetic data are summarized in Table 2 . In contrast to bovine IF 1 where the C-terminally truncated variant has a higher inhibitory potential than the intact protein at pH 8.0 [6] , K i , k on and k off do not differ between intact TbIF 1 and TbIF 1 (1-64).
This difference is unsurprising as TbIF 1 does not form tetramers, which is facilitated by the C-terminal part of IF 1 in the bovine protein [7] . Reduction of the pH to 6.5 is accompanied by a significant increase in the affinity of TbIF 1 for F 1 -ATPase (Table 2 ). In mammals, a similar phenomenon is explained by the need to prevent ATP depletion by hydrolysis by F-ATPase, accompanying membrane depolarization and acidification of the matrix [31] . The increased affinity of IF 1 affinity counteracts this hydrolysis and helps to maintain sufficient levels of ATP [32] . A similar mechanism may operate also in T. brucei during hypoxia [26] . At pH values of both 8.0 and 6.5, the deletion of C-terminus does not affect the binding of the inhibitor to F 1 -ATPase. Approximately two-fold decrease in k off and 10-fold increase in k on contributed to a lower value of K i at pH 6.5 in comparison to pH 8.0 (Table 2) , indicating that the inhibitor binds to the enzyme at a higher rate and, in addition, the inhibited complex is more stable under these conditions.
The ability of TbIF 1 to inhibit F 1 -ATPase could either increase gradually with decreasing pH or it could change sharply at a certain threshold pH value. To distinguish between these two possibilities, the purified F 1 -ATPase was inhibited with either intact TbIF 1 or TbIF 1 at pH values from 6.0 to 9.0 and residual ATPase activities were measured. The response of TbIF 1 inhibitory potential to pH change was gradual and had no threshold (Fig. 3) . Also, as expected, the lack of the C-terminal region of TbIF 1 had no effect on the inhibition F 1 -ATPase over a range of pH values, and for both intact and truncated TbIF 1 , the residual activities were very similar, consistent with the C-terminal part of TbIF 1 not being involved directly in the interaction with F 1 -ATPase, as in other species [8, 10] .
Effect of truncation of the N-terminal region of TbIF 1
The inhibitory capacities of TbIF 1 -D1-5, -D1-8, -D1-10, -D1-12, and -D1-15 were compared with full length TbIF 1 . It was confirmed that the inhibitory effect of intact TbIF 1 is greater at pH 6.5 than at pH 8.0, and that at pH 6.5 a concentration of 0.1 lM is more effective than the same concentration at pH 8.0 (Fig. 4A) .
Removal of the N-terminal region of TbIF 1 up to residue 10, had no effect on the inhibitory capacity of TbIF 1 , but removal of residues 1-12 and 1-15, impaired the inhibitory capacity of the protein progressively (Fig. 4B) . Thus, the region in the vicinity of residues 14-16 defines the N-terminal extremity of the minimal inhibitory sequence of TbIF 1 . At pH 8.0, the inhibitory capacities of all the truncated versions followed the same trend as at pH 6.5, except that the inhibitory capacities were lower (not shown), suggesting that the N-terminal region of TbIF 1 from residues 1-16 does not participate in the effects of pH on inhibitory activity.
In the structure of bovine F 1 -ATPase inhibited by IF 1 , residues 1-7 of IF 1 were not resolved and residues 8-13 have an extended structure [8] . Thus, the increased entropy of this region may destabilize the interaction of the enzyme with the inhibitor [27] . In the bovine inhibited complex, residues 14-18 form a short a-helix, followed by a short loop from residues 19-21 which interacts with the N-terminal a-helix in the a-helical coiled-coil region of the c-subunit. Despite the lack of conservation of this region of the sequence of the inhibitor protein in S. cerevisiae (Fig. 1A) , the yeast IF 1 interacts with its cognate F 1 -ATPase in a similar way [10] . The sequences of the Nterminal regions of TbIF 1 and bovine IF 1 also differ extensively (Fig. 1A) , and yet deletion of this region has a similar impact on their inhibitory capacities [27] . Therefore, as in the bovine and yeast inhibited complexes, it seems likely that in the complex of TbF 1 -ATPase inhibited by TbIF 1 , the N-terminal region of TbIF 1 will interact with TbF 1 -ATPase in a similar way to the mode of interaction of the bovine and yeast IF 1 proteins with their cognate F 1 -ATPases.
Effects of point mutations of TbIF 1 on inhibition of F 1 -ATPase
The N-terminal inhibitory domain of IF 1 contains several residues that are strictly conserved in mammals, fungi and kinetoplastids (Fig. 1A) . This conservation suggests that they have a general role in the action of IF 1 , either directly by participating in the interaction between IF 1 and F 1 -ATPase or indirectly in the process of formation of the inhibited complex, which is complicated by the requirement to fold the inhibitory region from its intrinsically disordered unbound state [9] . Introduction of the mutation Y36W into the conserved residue Tyr-36 of TbIF 1 increased the inhibitory potency of TbIF 1 (Fig. 4C) . This observation is consistent with the conservation of Asp-394 and Lys-401 in the b-subunit, which interact with Tyr-33 in the bovine inhibited complex (Table S2 and [8, 9] ). In bovine inhibited complex, residues 21-46 of the long a-helix of IF 1 are strictly or conservatively conserved in 14 of 26 residues in comparison to TbIF 1 , but not residue Pro-32, which replaces Glu-28 in bovine IF 1 . In addition to being unconserved, Glu-28 is not in contact with F 1 -ATPase in the inhibited complex. The introduction of a proline residue might be expected to change the secondary structure of TbIF 1 by breaking the long a-helix. However, the substitution of this residue by alanine in TbIF 1 (P32A) had only a slight effect on the inhibitory capacity of TbIF 1 (Fig. 4C) , and so it appears likely that this proline residue has only a minor structural effect on TbIF 1 , possibly introducing a kink in the long a-helix rather than changing its secondary structure radically. As expected, the mutation TbIF 1 (P32A) had no effect on the a-helical content of TbIF 1 alone, as this region of the protein is presumably disordered as in the unbound bovine IF 1 (Fig. 1C) .
Similar to bovine IF 1 and IF 1 in S. cerevisiae, the inhibitory activity of TbIF 1 is pH dependent (Fig. 3 ) [13] . It has been proposed that in the yeast protein, this pH dependence involves Glu-21 (residue 30 in the aligned sequences in Fig. 1A) . However, this glutamate residue is not conserved in kinetoplastids, and adjacent residues are also poorly conserved (Fig. 1A) . Therefore, two other nearby glutamate residues at positions 24 and 27 were mutated separately to alanine, generating TbI-F 1 (E24A) and TbIF 1 (E27A). However, neither mutation enhanced the inhibition of F 1 -ATPase at pH 8.0, and their inhibitory capacity at pH 6.5 remained the same as the inhibitory capacity of TbIF 1 -WT (Fig. 4C) . Thus, the sensitivity of the inhibitory potency of TbIF 1 to pH is explained neither by these point mutations, nor by a change in oligomerization state [6] . An explanation will need to be sought elsewhere.
Heterologous inhibitory effects of TbIF 1 and bovine IF 1
Bovine F 1 -ATPase was hardly inhibited at all by TbIF 1 , but bovine IF 1 had a significant inhibitory effect on the F 1 -ATPase from T. brucei, albeit considerably less than by TbIF 1 (Fig. 5 ). In the current absence of structure of TbF 1 -ATPase inhibited by TbIF 1 , it is difficult to explain these observations in molecular terms. However, most of residues in the b-subunit of bovine F 1 -ATPase involved in the interaction with bovine IF 1 [8, 9] are conserved in trypanosomes, whereas other interactions between bovine IF 1 with a-and c-subunits are generally poorly conserved (Table S2) . It is among these poorly conserved residues in a-and c-subunits that an explanation may lie. In the BF of T. brucei, the membrane potential of their mitochondria is maintained by the hydrolysis of ATP by ATP synthase. The ATP molecules are supplied from the cytosol and are imported to the mitochondrial matrix by the ADP--ATP translocase. The survival of the parasite in the bloodstream depends on this mechanism [25, 33] . Only recently has it been demonstrated that TbIF 1 suppresses the hypoxia-related mitochondrial membrane potential phenotype in the PF cells of T. brucei, and that in vivo TbIF 1 inhibits ATPase, but not ATP synthesis [26] . The experiments described here show common features and significant differences between TbIF 1 and the mammalian inhibitor protein.
The inhibitors inhibit the hydrolytic activity of their cognate F 1 -ATPases by probably binding to the enzyme in a similar way. However, they differ in their oligomeric state and in the regulation of their inhibitory activity by pH. Moreover, TbIF 1 has no effect on bovine F 1 -ATPase, which is very similar in its structure and properties to the human enzyme. Therefore, it is conceivable that compounds mimicking the action of TbIF 1 could be developed to inhibit the ATP hydrolytic activity of the BF of T. brucei, leading potentially to new therapies for the treatment of African trypanosomiases. Recently, the structure of the F 1 -ATPase from T. brucei was described [34] , and the development of such new therapeutic compounds would be greatly aided by an atomic resolution structure of the T. brucei F 1 -ATPase inhibited by TbIF 1 . The F-ATPase in Mycobacterium tuberculosis is an authenticated drug target for treatment of tuberculosis, and bedaquiline, an inhibitor of the enzyme, is now in clinical use [35, 36] . The current 
Experimental procedures
Cloning, expression, and purification of variants of TbIF 1
Fragments encoding truncated versions of TbIF 1 were amplified by PCR from genomic DNA from PF T. brucei Lister strain 427 with forward and reverse primers containing NdeI and HindIII restriction sites, respectively. All reverse primers encoded the hexahistidine tag (6xHis). The PCR products were inserted into the expression vector pRUN [37] , predigested with NdeI and HindIII. Site-directed mutagenesis was carried out with a QuikChange Lightning mutagenesis kit (Agilent Technologies, Santa Clara, CA, USA). Oligonucleotides used in amplification and mutagenesis are listed in the Table S3 . The sequences of cloned regions were verified by DNA sequencing. Plasmids were transformed into E. coli C41(DE3) [38] , and the cells were grown in LB medium. When the OD 600 had reached~0.4, the expression of the Purification of F 1 -ATPase F 1 -ATPase from T. brucei was purified from PF strain 427 as described previously [30] . Its specific activity was determined as described below [39] and was 56 lmolÁmin 
Protein analysis
The process of purification and the purity of recombinant 
Analytical gel-filtration
Purified TbIF 1 and bovine IF 1 , both at a concentration of 3 mgÁmL À1 , were dialyzed into buffers with various pH values: 20 mM Tris-HCl, pH 8.0 and 7.4, and 10 mM MOPSNaOH, pH 6.5. All buffers contained 10% (w/v) glycerol and 150 mM NaCl. The samples were applied to a Superdex 75 10/300 GL gel-filtration column (GE Healthcare) equilibrated in the respective buffer, and calibrated with a gel filtration LMW Calibration Kit (GE Healthcare). The uv absorption of the eluate was recorded at 280 nm.
Assay of inhibition of F 1 -ATPase
The activity of TbF 1 -ATPase was measured with an ATPregenerating assay as described before [27, 39] . For estimation of the inhibitory effects of TbIF 1 , ATP hydrolysis by F 1 -ATPase was initiated, and 15 s later the inhibitor protein was introduced in buffer containing 20 mM Tris-HCl, pH 7.4 and 10% (w/v) glycerol, and the absorbance was recorded for 10 min. The initial exponential decay of the ATPase activity following inhibition is described by the equation:
where y t is absorbance at time t, y 0 is absorbance at the point of inhibitor addition, V 0 is the initial rate of the reaction before the addition of inhibitor, V ∞ is rate of reaction at equilibrium, and k inh is the apparent inhibitory constant. In the presence of a large molar excess of the inhibitor over the enzyme, the reaction can be assessed as pseudo-first order, and k inh , expressed in reciprocal seconds (s À1 ), is directly proportional to the concentration of inhibitor ([I]):
Therefore, the slope of the linear regression of k inh plotted against [I] corresponds to the rate constant of the binding of the inhibitor, k on , expressed as lM À1 Ás À1 . To obtain K i , the dissociation constant of the inhibitor binding to the enzyme complex, expressed as lM, the ratio of final and initial reaction rates (V ∞ /V 0 ) was fitted to the equation:
where v ins is the inhibitor insensitive fraction of the initial rate of reaction; its value was set to the proportion of the initial ATPase activity which cannot be inhibited by the specific F 1 -ATPase inhibitor sodium azide. The rate constant of inhibitor dissociation, k off , expressed as s
À1
, was calculated directly from the following relationship derived from Eqns (2) and (3):
Theoretically, k off is given also by the intercept of the y axis of Eqn (2) . However, the approach using Eqn (4) is independent of [I] , which eliminates any impact of possible inaccuracies at the concentrations of inhibitor solutions. An example of data processing and calculations is shown in Fig. 6 .
To measure the residual F 1 -ATPase activity in equilibrium with different inhibitor variants, F 1 -ATPase was mixed with the inhibitor in 500 lL of assay mixture lacking NADH, phosphoenolpyruvate, pyruvate kinase and lactate dehydrogenase. After 5 min at 37°C, when the equilibrium had been reached, a further 500 lL of reaction mixture containing at twice their normal concentrations of constituents to compensate for their absence in the first half of the mixture were added, and the linear decrease of absorbance was recorded for 60 s. The residual ATPase activity was calculated as the ratio of decrease of absorbance in the presence and absence of inhibitor. (2)). The ratio V ∞ /V 0 was plotted against [I] and the data fitted to Eqn (3) to obtain K i . In order to obtain k off , the ratio V ∞ /V 0 was plotted against 1/k inh and data were fitted into the linear Eqn (4).
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